封面
市场调查报告书
商品编码
1820477

全球基因组学服务市场研究报告 - 产业分析、规模、份额、成长、趋势及预测(2025 年至 2033 年)

Global Genomics Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: | 出版商: Value Market Research | 英文 138 Pages | 商品交期: 最快1-2个工作天内

价格

预计 2025 年至 2033 年间,全球基因组学服务市场将以 11.66% 的显着复合年增长率成长。到 2033 年,市场规模预计将飙升至 243.1 亿美元,较 2024 年的 90.1 亿美元大幅成长。

受定序技术、生物资讯学和个人化医疗领域突破性进展的推动,基因组学服务市场正经历指数级增长。基因组学服务涵盖广泛的服务,包括全基因组定序、基因表现分析和变异解读,为科学研究、临床诊断和药物开发提供支援。定序成本和周转时间的大幅缩短,使基因组资料的取得更加便捷,进而帮助大规模人口研究和精准医疗应用。云端平台和人工智慧驱动的分析技术正在增强资料处理能力,促进从复杂的基因组数据集中获取切实可行的洞察。

基因组学与其他组学学科和电子健康记录的整合正在推动多维度患者分析,改善疾病风险预测、诊断和个人化治疗。监管框架和资料隐私考量正在塑造服务交付模式,强调安全的资料管理和合乎伦理的资料使用。直接面向消费者的基因组学和药物基因组学服务的扩展正在提高公众的参与和认知。此外,学术机构、生物技术公司和医疗保健提供者之间的合作正在加速转化研究和临床应用。

随着基因组学成为未来医学和生物技术的核心,市场将持续成长,推动诊断、治疗和人口健康管理的创新。

我们的报告经过精心设计,旨在为客户提供关于各个行业和市场的全面且切实可行的洞察。每份报告都包含几个关键部分,以确保客户全面了解市场格局:

市场概况:对市场的详细介绍,包括定义、分类和行业现状概述。

市场动态:深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本部分探讨技术进步、监管变化和新兴趋势等因素。

細項分析:根据产品类型、应用、最终用户和地理位置等标准,将市场细分为不同的细分市场。此分析重点在于突出每个细分市场的表现和潜力。

竞争格局:对主要市场参与者的全面评估,包括其市场份额、产品组合、策略倡议和财务表现。本部分深入分析了领先公司的竞争动态和关键策略。

市场预测:根据历史资料和当前市场状况,对特定时期的市场规模和成长趋势进行预测。这包括定量分析和图形表示,以说明未来的市场发展轨迹。

区域分析:评估不同地理区域的市场表现,确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会:识别当前及新兴市场趋势、技术创新和潜在投资领域。本部分提供对未来市场发展和成长前景的洞察。

涵盖的细分市场列表

基因组学服务市场报告的此部分提供了国家和地区层面的细分详细资料,从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按服务类型

  • 下一代定序
  • 基因分型
  • 微阵列
  • 桑格定序
  • 其他服务

按应用

  • 研究
  • 诊断

按最终用途

  • 研究机构
  • 诊断中心
  • 製药和生物技术公司
  • 合约研究组织(CRO)
  • 其他最终用途
  • 报告中介绍的公司列表
  • 23andMe、安捷伦科技、BGI Genomics、Bio Rad Laboratories、Color Genomics、丹纳赫、Eurofins Scientific、F. Hoffmann-La Roche、GE Healthcare、GENEWIZ (Azenta)、Illumina、LGC、Macrogen、IQVIA、QIAGEN

如果您有任何客製化需求,请联络我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告描述
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究流程
    • 市场研究方法

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第三章:基因组学服务 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 按服务类型分析市场吸引力
    • 市场吸引力分析:按应用
    • 按最终用途进行的市场吸引力分析
    • 市场吸引力分析:按地区

第四章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料製造商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第五章:全球基因体学服务市场分析:依服务类型

  • 依服务类型概览
  • 按服务类型分析历史和预测数据
  • 下一代定序
  • 基因分型
  • 微阵列
  • 桑格定序
  • 其他服务

第六章:全球基因组学服务市场分析:按应用

  • 概述:按应用
  • 历史和预测数据分析:按应用
  • 研究
  • 诊断

第七章:全球基因组学服务市场分析:依最终用途

  • 按最终用途概览
  • 按最终用途进行的历史和预测数据分析
  • 研究机构
  • 诊断中心
  • 製药和生物技术公司
  • 合约研究组织(CRO)
  • 其他最终用途

第 8 章:全球基因组学服务市场分析:按地区

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美各细分市场销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲各细分市场销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲分部销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第九章:基因组学服务公司的竞争格局

  • 基因组学服务市场竞争
  • 伙伴关係/合作/协议
  • 併购
  • 新产品发布
  • 其他发展

第十章:公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • 23andMe
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Agilent Technologies
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BGI Genomics
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bio Rad Laboratories
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Color Genomics
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Danaher
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Eurofins Scientific
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • F. Hoffmann-La Roche
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • GE Healthcare
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • GENEWIZ (Azenta)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Illumina
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • LGC
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Macrogen
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • IQVIA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • QIAGEN
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

注意 - 在公司简介中,财务细节和最新发展取决于可用性,或者在私人公司的情况下可能不涵盖

Product Code: VMR112117547

The Global Genomics Services market is forecasted to grow at a noteworthy CAGR of 11.66% between 2025 and 2033. By 2033, market size is expected to surge to USD 24.31 Billion, a substantial rise from the USD 9.01 Billion recorded in 2024.

The genomics services market is experiencing exponential growth fueled by breakthroughs in sequencing technologies, bioinformatics, and personalized medicine. Genomics services encompass a broad spectrum of offerings, including whole-genome sequencing, gene expression analysis, and variant interpretation, supporting research, clinical diagnostics, and drug development. The dramatic reduction in sequencing costs and turnaround times is democratizing access to genomic data, enabling large-scale population studies and precision healthcare applications. Cloud-based platforms and AI-driven analytics are enhancing data processing capabilities, facilitating actionable insights from complex genomic datasets.

The integration of genomics with other omics disciplines and electronic health records is advancing multi-dimensional patient profiling, improving disease risk prediction, diagnosis, and treatment customization. Regulatory frameworks and data privacy considerations are shaping service delivery models, emphasizing secure data management and ethical use. The expansion of direct-to-consumer genomics and pharmacogenomics services is increasing public engagement and awareness. Additionally, collaborations between academic institutions, biotech firms, and healthcare providers are accelerating translational research and clinical adoption.

As genomics becomes central to the future of medicine and biotechnology, the market is poised for sustained growth, driving innovation in diagnostics, therapeutics, and population health management.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Genomics Services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service Type

  • Next Generation Sequencing
  • Genotyping
  • Microarray
  • Sanger Sequencing
  • Other Services

By Application

  • Research
  • Diagnostics

By End Use

  • Research Institutes
  • Diagnostic Centers
  • Pharmaceutical and Biotechnological Companies
  • Contract Research Organizations (CROs)
  • Other End Use
  • List of Companies Profiled in the report
  • 23andMe, Agilent Technologies, BGI Genomics, Bio Rad Laboratories, Color Genomics, Danaher, Eurofins Scientific, F. Hoffmann-La Roche, GE Healthcare, GENEWIZ (Azenta), Illumina, LGC, Macrogen, IQVIA, QIAGEN

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. GENOMICS SERVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Service Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End Use
    • 3.7.4 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL GENOMICS SERVICES MARKET ANALYSIS BY SERVICE TYPE

  • 5.1. Overview By Service Type
  • 5.2. Historical and Forecast Data Analysis By Service Type
  • 5.3. Next Generation Sequencing Historic and Forecast Sales By Regions
  • 5.4. Genotyping Historic and Forecast Sales By Regions
  • 5.5. Microarray Historic and Forecast Sales By Regions
  • 5.6. Sanger Sequencing Historic and Forecast Sales By Regions
  • 5.7. Other Services Historic and Forecast Sales By Regions

6. GLOBAL GENOMICS SERVICES MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Research Historic and Forecast Sales By Regions
  • 6.4. Diagnostics Historic and Forecast Sales By Regions

7. GLOBAL GENOMICS SERVICES MARKET ANALYSIS BY END USE

  • 7.1. Overview By End Use
  • 7.2. Historical and Forecast Data Analysis By End Use
  • 7.3. Research Institutes Historic and Forecast Sales By Regions
  • 7.4. Diagnostic Centers Historic and Forecast Sales By Regions
  • 7.5. Pharmaceutical and Biotechnological Companies Historic and Forecast Sales By Regions
  • 7.6. Contract Research Organizations (CROs) Historic and Forecast Sales By Regions
  • 7.7. Other End Use Historic and Forecast Sales By Regions

8. GLOBAL GENOMICS SERVICES MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE GENOMICS SERVICES COMPANIES

  • 9.1. Genomics Services Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF GENOMICS SERVICES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. 23andMe
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Agilent Technologies
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. BGI Genomics
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Bio Rad Laboratories
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Color Genomics
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Danaher
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Eurofins Scientific
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. F. Hoffmann-La Roche
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. GE Healthcare
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. GENEWIZ (Azenta)
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Illumina
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. LGC
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Macrogen
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. IQVIA
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments
  • 10.17. QIAGEN
    • 10.17.1 Company Overview
    • 10.17.2 Company Revenue
    • 10.17.3 Products
    • 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Service Type (USD MN)
  • Next Generation Sequencing Market Sales By Geography (USD MN)
  • Genotyping Market Sales By Geography (USD MN)
  • Microarray Market Sales By Geography (USD MN)
  • Sanger Sequencing Market Sales By Geography (USD MN)
  • Other Services Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Diagnostics Market Sales By Geography (USD MN)
  • Analysis By End Use (USD MN)
  • Research Institutes Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Pharmaceutical and Biotechnological Companies Market Sales By Geography (USD MN)
  • Contract Research Organizations (CROs) Market Sales By Geography (USD MN)
  • Other End Use Market Sales By Geography (USD MN)
  • Global Genomics Services Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Genomics Services Report
  • Market Research Process
  • Market Research Methodology
  • Global Genomics Services Market Size, By Regions (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Service Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End Use
  • Market Attractiveness Analysis By Regions
  • Value Chain Analysis
  • Global Market Analysis By Service Type (USD MN)
  • Next Generation Sequencing Market Sales By Geography (USD MN)
  • Genotyping Market Sales By Geography (USD MN)
  • Microarray Market Sales By Geography (USD MN)
  • Sanger Sequencing Market Sales By Geography (USD MN)
  • Other Services Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Diagnostics Market Sales By Geography (USD MN)
  • Global Market Analysis By End Use (USD MN)
  • Research Institutes Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Pharmaceutical and Biotechnological Companies Market Sales By Geography (USD MN)
  • Contract Research Organizations (CROs) Market Sales By Geography (USD MN)
  • Other End Use Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.